Buruli ulcer disease is a bacterial skin infection that causes painless swelling or nodules that break down into deep ulcers. The ulcers can enlarge over weeks to months and may scar, and bones or joints can be affected in severe cases. People with Buruli ulcer disease are often children and adolescents in tropical and subtropical regions, but adults can be affected too. Treatment usually includes a several-week course of antibiotics and proper wound care, and surgery may be needed for large areas. Most people recover with timely care, but delayed treatment can lead to disability and, rarely, serious complications.
Overview
Buruli ulcer diseaseSymptoms
Buruli ulcer disease often begins with a painless swelling, nodule, or patch on an arm or leg. Early symptoms of Buruli ulcer disease can progress to a deep, enlarging skin ulcer with undermined edges. Pain is usually mild unless infected.
Outlook and prognosis
Most people with Buruli ulcer disease do well when treatment starts early, with healing over weeks to months. Antibiotics and proper wound care usually stop the infection and limit scarring, helping people return to daily activities. Delays in care can mean larger ulcers, skin grafts, and longer recovery.
Causes and risk factors
Buruli ulcer disease is caused by Mycobacterium ulcerans, likely from environmental exposure around stagnant or slow-moving water. Risk increases in endemic tropical regions, with skin injuries and limited protective clothing. Children and people with weakened immunity are more vulnerable.
Genetic influences
Genetics plays a minor role in Buruli ulcer disease. The main driver is environmental exposure to Mycobacterium ulcerans, though common immune-related variations may slightly influence susceptibility and healing. Family history rarely changes risk compared with exposure.
Diagnosis
Buruli ulcer disease is diagnosed by examining the skin lesion and exposure history, then confirming with a PCR test on a swab or biopsy. Microscopy, culture, or histology may support results. Early diagnosis of Buruli ulcer disease improves treatment success.
Treatment and drugs
Treatment focuses on prompt antibiotics and careful wound care to stop tissue damage and support healing. Most people with Buruli ulcer disease receive a combination of rifampicin with another antibiotic, plus dressings; sometimes limited surgery or skin grafting helps. Pain control, nutrition, and rehabilitation protect function and mobility.
Symptoms
Buruli ulcer disease often begins quietly, with a firm, painless lump or patch on the skin, usually on an arm or leg. You might notice small changes at first—swelling that doesn’t hurt, a tight patch, or warmth without fever. Over days to weeks, the area can soften and break down into an open sore with undercut edges. Spotting the early symptoms of Buruli ulcer disease can help you seek care before tissue loss becomes significant.
A firm, raised spot or flat thickened area may appear on the skin without hurting. This is often the first sign of Buruli ulcer disease.
A whole section of a limb can become puffy and tense without a clear lump. The skin may feel warm but not tender.
Early lesions typically don’t hurt even when pressed. This quiet start is typical of Buruli ulcer disease.
After days to weeks, the surface can break down into a sore that slowly enlarges. The center may look yellowish with soft, dead tissue while the edges look thin and fragile.
How people usually first notice Buruli ulcer disease?
People often first notice Buruli ulcer disease as a painless, firm swelling or nodule under the skin that slowly enlarges over days to weeks, sometimes mistaken for a bug bite or bruise. As the infection progresses, the center can thin and break down into a shallow ulcer with undermined edges, still oddly painless despite its size, and nearby skin may feel warm or look swollen. Many seek care when the ulcer doesn’t heal, keeps expanding, or is joined by new painless patches—these are common first signs of Buruli ulcer disease.
Types of Buruli ulcer disease
Buruli ulcer disease has a few recognized clinical forms that reflect how deep and extensive the infection becomes and, in some cases, how it starts. People may notice different sets of symptoms depending on their situation. Broadly, clinicians describe patterns based on whether the skin is initially swollen, ulcerated, or forming lumps, and whether the infection reaches deeper layers like fascia and bone. Understanding the main types of Buruli ulcer disease can help you and your care team discuss early symptoms of Buruli ulcer disease and what to expect during treatment.
Nodular form
Small, firm, painless lumps appear under the skin, often on a limb. The overlying skin may look normal at first but can thin over days to weeks. Without treatment, the nodule can break down into an ulcer.
Plaque form
A broader, raised, firm area develops that may feel like a thick patch. The surface can be taut and slightly shiny, with little or no pain. Plaques can expand and later ulcerate if not treated.
Edematous form
Diffuse, painless swelling affects a limb or face and can look like a sudden puffiness. The skin may feel warm and tense, and movement can become limited. This form can progress quickly and may be mistaken for cellulitis.
Ulcerative form
A well-defined skin ulcer forms with undermined edges and a clean-looking base. Pain is often mild compared with the size of the wound. Without care, the ulcer can enlarge and leave scarring or contracture.
Osteomyelitic involvement
Infection extends into bone from an overlying lesion, causing deep, persistent swelling and tenderness. X-rays or scans may show bone changes that need longer antibiotics. This deeper spread raises the risk of long-term stiffness.
Multifocal disease
More than one site is involved at the same time, sometimes on different limbs. Lesions can be nodular, plaque-like, or ulcerative in different spots. This pattern may require broader evaluation to guide therapy.
What genetics can tell you about symptoms
Certain genetic variants in immune genes like SLC11A1 and PARK2 may weaken early defenses against Mycobacterium ulcerans, making painless skin nodules progress to ulcers. Differences in IL-10 or TNF signaling can shift inflammation, influencing how fast ulcers expand and how much tissue dies.
Causes and risk factors
Buruli ulcer disease is caused by infection with a bacterium called Mycobacterium ulcerans. It is linked to slow or stagnant water and wetlands, and in some regions possibly to insect bites. Risk is higher if you spend time near rivers or swamps, have skin cuts, or lack protective clothing and wound care, so watch for early symptoms of Buruli ulcer disease. There are no known inherited genetic risks, and children, older adults, or people with weaker immune systems may be more vulnerable. Doctors distinguish between risk factors you can change and those you can’t.
Environmental and biological risk factors
Buruli ulcer disease is linked to certain places and exposures in the environment, along with how the body's defenses are working. Two people with the same exposure can react very differently—biology shapes the response. Knowing the early symptoms of Buruli ulcer disease helps with prompt care, but here the focus is on what raises risk in the first place. Below are key environmental and biological factors scientists have identified.
Regular contact with slow-moving or stagnant water, like swamps, ponds, or wetlands, increases exposure to the bacteria. People living or working near these waterways have higher risk of Buruli ulcer disease.
Cases often rise after heavy rains or flooding in endemic regions. Water level changes can spread the bacteria into soil and shorelines people touch.
Living in or visiting areas where Buruli ulcer disease is present raises baseline exposure. Rural zones near rivers, floodplains, or wetlands are most affected.
In some regions, higher mosquito activity aligns with more cases, suggesting a possible role in spread. The exact way the bacteria moves from the environment to skin is still being studied.
Genetic risk factors
Genetic makeup seems to influence who develops Buruli ulcer disease and how extensive the ulcers become. Carrying a genetic change doesn’t guarantee the condition will appear, but it may change the odds or affect healing. Scientists are studying genetic risk factors for Buruli ulcer disease, and several immune-system pathways have emerged as promising clues. Many findings point to genes that shape early immune defenses and how the body regulates inflammation and repair.
Innate immunity genes: Differences in genes that help frontline immune cells control bacteria, such as SLC11A1 (also called NRAMP1), have been linked to susceptibility in some studies. These variants may change how well cells limit bacterial growth and could influence who develops Buruli ulcer disease.
HLA types: Variations in human leukocyte antigen (HLA) genes can shape T cells’ responses to Mycobacterium ulcerans. Certain HLA patterns have been associated with higher or lower risk of Buruli ulcer disease in specific populations.
Interferon-gamma pathway: Common differences in genes that drive interferon-gamma and interleukin-12 signaling can affect how strongly the immune system responds to mycobacteria. Weaker signaling may increase susceptibility or lead to more extensive ulcers in Buruli ulcer disease.
Autophagy genes: Variants in genes that control cellular cleanup of germs (autophagy) may alter how efficiently infected cells clear bacteria. This can influence both risk of Buruli ulcer disease and the pace of healing.
Toll-like receptors: Changes in toll-like receptor (TLR) pathway genes, which help the body sense bacterial components, have been tied to different levels of susceptibility to Buruli ulcer disease in some studies. These variants can shift early immune signaling and inflammation.
TNF/IL-10 balance: Genetic differences that tilt the balance between pro-inflammatory signals like TNF and anti-inflammatory signals like IL-10 can affect tissue damage. These variants may influence ulcer size, scarring, and recovery in Buruli ulcer disease.
Lifestyle risk factors
Buruli ulcer disease is an infection where daily habits can influence both the chance of infection and how well ulcers heal once they appear. The lifestyle risk factors for Buruli ulcer disease are mostly about skin care, timely care-seeking, and behaviors that affect immunity and wound healing. Diet and physical habits can also shape recovery from treatment.
Minor cuts or scrapes left uncleaned can give bacteria an entry point. Washing, disinfecting, and covering skin breaks lowers risk and supports faster healing.
Waiting to see a clinician allows ulcers to expand and invade deeper tissue. Early evaluation and antibiotics improve healing and reduce complications.
Tobacco toxins reduce skin blood flow and weaken local immune defenses. Smokers tend to heal more slowly and face higher risks of infection spread.
Low protein, iron, zinc, or vitamin C intake weakens skin repair and immune response. Eating enough protein and micronutrients supports wound closure during treatment.
Risk prevention
Daily habits can lower the chance of skin exposure to the germ that causes Buruli ulcer disease. Prevention is about lowering risk, not eliminating it completely. Most steps focus on avoiding contact with stagnant or slow-moving freshwater, protecting skin from bites and scrapes, and caring for minor wounds quickly. Early attention to a painless bump or swelling can also reduce how severe the infection becomes.
Wear long sleeves, long trousers, and closed shoes when near swamps, riverbanks, or wetlands. Covering skin reduces contact with contaminated water and muddy surfaces. This is especially helpful in areas where Buruli ulcer disease is known.
Use repellent with DEET or picaridin on exposed skin and clothing. Sleep under bed nets where biting insects are common. Bite prevention may lower the chance of exposure in regions where insects could spread the bacteria.
Avoid wading, swimming, or washing in stagnant or slow-moving freshwater in endemic areas. If contact is unavoidable, keep cuts covered with waterproof dressings and rinse skin afterward. Choose treated or well-maintained pools instead of natural ponds when possible.
Clean any cut, scratch, or puncture right away with soap and safe water. Apply an antiseptic if available and cover with a clean bandage. Change the dressing daily or if it gets wet or dirty.
Transmission
Buruli ulcer disease does not appear to spread from person to person; everyday contact, sharing a home, or touching someone’s bandaged wound doesn’t pass it on. The bacteria live in the environment, especially around slow‑moving water and wetland soil, and most infections likely start when they enter through small breaks in the skin after contact with contaminated water or mud; in some areas, particularly parts of Australia, mosquito exposure has been linked to cases. Because of this environmental route, Buruli ulcer disease is considered minimally contagious, and people with it are not a risk to family or caregivers when wounds are properly covered. If you’re wondering how Buruli ulcer disease spreads, the practical takeaway is that it’s an environmental exposure rather than person-to-person transmission.
When to test your genes
Because Buruli ulcer is caused by a bacterium, routine genetic testing isn’t needed for diagnosis or care. Consider genetic testing only if multiple close relatives have had unusually severe, recurrent skin or soft‑tissue infections, suggesting rare immune system variants. Otherwise, seek prompt medical evaluation for any painless swelling or nonhealing ulcer.
Diagnosis
You might notice a painless bump or sore that slowly enlarges and doesn’t heal, sometimes after travel or outdoor exposure. Doctors usually begin with a careful look at the skin and nearby tissues and ask about where you’ve lived or traveled. Because early symptoms of Buruli ulcer disease can resemble other skin problems, lab tests help confirm the cause. Understanding how the diagnosis of Buruli ulcer disease is made can guide timely treatment.
Your clinician asks about symptom timing, insect bites, water exposure, and travel or residence in areas where Buruli ulcer disease occurs. They also examine the skin and nearby lymph nodes and note the size and location of the sore.
A swab from the base of the ulcer is tested for the bacterium’s genetic material using PCR. This rapid test supports the diagnosis of Buruli ulcer disease and helps confirm the cause early.
A small sample from the edge of the lesion is taken for lab analysis. Pathology can show characteristic tissue changes and help distinguish Buruli ulcer disease from other infections or skin conditions.
A smear from swab or tissue is stained and examined for acid-fast bacteria. While less sensitive than PCR, a positive result adds weight to the diagnosis.
Stages of Buruli ulcer disease
Buruli ulcer disease often moves through predictable stages, and timing matters for treatment. Early symptoms of Buruli ulcer disease can be subtle, like a painless lump or swelling. Early and accurate diagnosis helps you plan ahead with confidence.
Early pre-ulcer
A firm, painless bump, patch, or swelling may appear on an arm or leg. Skin usually looks normal on top and isn’t warm or tender.
Ulcerative stage
The skin breaks down into a shallow ulcer with soft, undermined edges and a clean-looking base. It may still be painless unless there’s a secondary infection.
Advanced spread
Ulcers can enlarge or become multiple, sometimes extending into deeper tissues or bone, which can cause pain and limit movement. Larger lesions may be over 15 cm (about 6 in) across and can occur near joints.
Healing and scarring
With treatment, the ulcer fills in and closes, leaving a scar that can tighten the skin. Some people living with Buruli ulcer disease develop stiffness, contractures, or color changes that benefit from rehab and follow-up.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, especially after a new diagnosis of Buruli ulcer disease. Most people recover well with a full course of antibiotics and proper wound care, but healing can take months. Scars and tightness around joints are the main long-term issues, which can affect walking, gripping, or daily chores if ulcers were large or near joints. Early care can make a real difference, because treating small lesions early lowers the chance of scarring, disability, and repeat procedures.
Doctors call this the prognosis—a medical word for likely outcomes. For early, limited Buruli ulcer disease, the outlook is generally very good, with high cure rates and low risk of relapse once antibiotics are completed. Larger or deep ulcers may need surgery and longer rehab, and some people are left with stiffness or limb length changes if growth plates were involved in childhood. Death from Buruli ulcer is uncommon, but it can occur in severe, untreated cases or when other serious illnesses are present.
Looking at the long-term picture can be helpful. After treatment, most people return to usual activities, though skin sensation and strength may take time to recover. The risk of the same spot reopening is low after full healing, but new lesions can appear, so noticing early symptoms of Buruli ulcer disease—like a painless swelling or nodule—matters. Talk with your doctor about what your personal outlook might look like, including plans for scar management, physical therapy, and follow-up to catch any changes early.
Long-term effects
Early symptoms of Buruli ulcer disease are often painless, but the after‑effects can last well beyond wound healing. Scars may tighten skin, pull on nearby joints, and change how an arm or leg moves. Long-term effects vary widely, depending on ulcer size, depth, and whether bone was involved. Many people heal fully, while others live with lasting changes in movement, sensation, or appearance.
Healed ulcers usually leave firm scars that can feel tight. Tight skin may limit stretch and fine movement near the area.
When an ulcer crosses a joint, healing can shorten skin and soft tissue. This can hold a joint in a bent or stiff position over time.
Stiffness around scars may reduce reach, grip, or walking speed. For many, this can mean difficulty with tasks like squatting or climbing stairs.
Damage to lymph channels can leave lasting swelling in the hand, arm, foot, or leg. Swelling may fluctuate and can make the limb feel heavy.
How is it to live with Buruli ulcer disease?
Living with Buruli ulcer disease often starts with a painless swelling or nodule that slowly enlarges, then breaks down into an ulcer that can limit movement, sleep, and daily tasks like walking, bathing, or working—especially if it’s on a limb. Treatment usually involves weeks of antibiotics and careful wound care, which can be time‑consuming and sometimes requires clinic visits or help from others. Many find the social impact just as real as the physical one: visible ulcers, dressings, or scarring can invite unwanted attention, while family and friends often take on caregiving roles, adjust routines, and help with transportation. With timely treatment and rehabilitation, most people heal, though some may have lasting stiffness or scarring that calls for ongoing exercises and practical adaptations at home and work.
Treatment and drugs
Buruli ulcer disease is treated mainly with antibiotics to stop the bacteria and prevent the ulcer from getting larger. Doctors usually prescribe a combination—commonly rifampin plus another antibiotic—for about 8 weeks, and they may add pain relief, wound care, and gentle dressings to help the skin heal. If a wound is large or leaves a deep cavity, minor surgery or a skin graft may be recommended after antibiotics have controlled the infection. Alongside medical treatment, lifestyle choices play a role, including keeping the area clean and protected and attending regular follow-ups to monitor healing and limit scarring or stiffness. Ask your doctor about the best starting point for you.
Non-drug treatment
For Buruli ulcer disease, non-drug care focuses on closing wounds, protecting movement, and supporting day-to-day function during recovery. Alongside medicines, non-drug therapies can help wounds heal, reduce scarring, and prevent long-term stiffness. Care is usually tailored to the size and location of the ulcer and your overall health. Early, steady support often improves comfort and long-term outcomes.
Regular gentle cleaning and moist dressings protect the area and support healing. Proper padding helps reduce odor and irritation. Your care team will choose dressings that fit the wound’s stage.
Removing dead tissue and closing gaps can speed healing and lower the risk of contractures. Skin grafts may be used for larger areas to restore coverage and movement.
Carefully applied local heat in a clinic can help shrink small lesions in selected cases. Trained staff monitor temperature and timing to protect healthy skin.
Splints keep a limb in a good functional position while the ulcer heals. Proper positioning reduces strain on the wound and helps prevent joint stiffness.
Your genes may have an impact on how drugs work for you
Antibiotics for Buruli ulcer disease can work differently from person to person because genes affect how fast the body activates, breaks down, or clears these drugs. Genetic differences may change side‑effect risk or dosing needs, so clinicians sometimes adjust treatment accordingly.
Pharmacological treatments
Antibiotics are the mainstay of treatment and can stop the infection so the skin can heal. Most people receive two antibiotics together for about 8 weeks, often without needing surgery. First-line medications are those doctors usually try first, based on international guidance and what’s safest for you. Your care team may adjust the plan if you’re pregnant, on other medicines, or have kidney or hearing concerns.
This all-oral pair is a common first choice for Buruli ulcer disease and is usually taken for 8 weeks. It works well even for early symptoms of Buruli ulcer disease, helping limit tissue damage. Possible effects include orange-colored urine (harmless) and stomach upset.
This combines a daily oral pill with a daily injection, used when macrolides like clarithromycin aren’t suitable. It treats Buruli ulcer disease effectively but needs monitoring for hearing and kidney side effects. It’s generally avoided during pregnancy.
This oral option is considered when clarithromycin can’t be used or isn’t tolerated. It can help clear Buruli ulcer disease but may affect heart rhythm and tendons, so doctors weigh risks carefully. It’s usually avoided in children and during pregnancy.
This pairs a pill with an injectable antibiotic when other options aren’t a good fit. It can control Buruli ulcer disease but requires close checks of kidney function and hearing. Treatment is typically given for about 8 weeks.
Genetic influences
In Buruli ulcer disease, the biggest factor is exposure to the bacteria in certain environments; still, your genes can influence how your immune system responds. Genetics is only one piece of the puzzle, but small inherited differences in immune pathways may make someone more likely to develop an ulcer after exposure or to have a more extensive infection. Think of some genes as working like dimmer switches, shaping how strongly inflammation turns on, how quickly the body controls the bacteria, and how well the skin repairs itself. Buruli ulcer disease isn’t considered an inherited disorder, and it doesn’t follow a clear family pattern; most family clusters reflect shared environmental exposure more than shared genes. There’s no routine genetic test to predict risk, and having a relative with Buruli ulcer disease doesn’t mean you’ll develop it. Researchers are studying which immune-related genes affect susceptibility and healing, with the hope of improving prevention and treatment over time.
Is Buruli ulcer disease genetic?
Genetics plays a minor role in Buruli ulcer disease. The main driver is environmental exposure to Mycobacterium ulcerans, though common immune-related variations may slightly influence susceptibility and healing. Family history rarely changes risk compared with exposure.
Pharmacogenetics—how genetics influence drug effects
Treatment for Buruli ulcer disease relies on antibiotics like rifampicin paired with clarithromycin, and in some settings older injectable antibiotics such as streptomycin are still used. Your genes can influence how you handle these medicines and whether you’re more likely to feel side effects. A well-established example is a specific change in the mitochondrial genes that makes some people extremely sensitive to aminoglycosides, with a higher risk of sudden, permanent hearing loss; if this kind of drug is needed for Buruli ulcer disease, doctors may choose another option or monitor hearing very closely.
Differences in the liver enzymes that break down clarithromycin can change how quickly it leaves your body, which may affect the dose or the chance of side effects and drug interactions. Genetic testing can sometimes identify how your body handles these antibiotics, helping your care team tailor the choice or dose. Still, pharmacogenetics is only part of the picture in Buruli ulcer disease treatment—other medicines you take, liver health, age, pregnancy, and nutrition also guide decisions, and genetic testing isn’t yet routine for most people.
Interactions with other conditions
Living with a large, open ulcer can be tougher when another condition is in the mix, because diabetes, poor circulation, or malnutrition may slow wound healing and raise the chance of added infection. Doctors call it a “comorbidity” when two conditions occur together. In people with HIV, Buruli ulcer disease can be more extensive and slower to heal; HIV care is important, and some HIV medicines may need adjusting because standard antibiotics for Buruli ulcer disease can affect how they work. Open skin also increases the risk of tetanus and secondary bacterial infections, so keeping up-to-date with tetanus vaccination and careful wound care matters. In regions where tuberculosis or leprosy are common, early symptoms of Buruli ulcer disease—like a painless nodule or swelling—can be mistaken for something else, and bone involvement can look similar, so assessment by a clinician familiar with these diseases helps. Nutrition, anemia, and other chronic illnesses can influence recovery time, which is why coordinated care across specialties often leads to better outcomes.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described slow, painless sores that expanded over weeks, sometimes leaving deep craters in the skin and scars that limited movement. Families and communities once noticed patterns—swollen nodules after a swim in a river or a pond, a small itch that became a wide ulcer, a child missing school while a wound seemed strangely calm yet kept growing. Oral histories preserved how wounds were dressed with plant leaves, clay, or oils, and how recovery could take months.
First described in the medical literature as large skin ulcers in parts of what is now Uganda and the Democratic Republic of the Congo in the late 19th and early 20th centuries, the condition gradually came to be known as Buruli ulcer disease. Early reports focused on its striking size and its odd lack of pain, even as tissue broke down. From these first observations, doctors recognized it as different from other tropical skin infections, which were usually hot, red, and tender.
Over time, descriptions became more precise as clinicians linked Buruli ulcer disease to living near wetlands and slow-moving water. In the mid-20th century, researchers connected the illness to a specific bacterium that thrives in the environment. This discovery explained why the earliest symptoms of Buruli ulcer disease could start as a firm, painless bump that later opened into an ulcer: the bacteria release a toxin that damages skin and soft tissue while quieting inflammation, so the wound often looks calm on the surface.
In recent decades, knowledge has built on a long tradition of observation. Community mapping showed clusters near rivers and floodplains in West and Central Africa, with additional pockets in Australia, parts of Asia, and the Americas. Public health programs refined case definitions, trained local health workers to recognize typical features, and promoted earlier diagnosis. As medical science evolved, treatment shifted from surgery alone to combinations of antibiotics, which helped control the infection and reduce the need for extensive operations.
Not every early description was complete, yet together they built the foundation of today’s knowledge. Historical differences highlight why some regions used different names or approaches, and why access to care shaped outcomes. Building on this early work, scientists continue to study how people come into contact with the bacterium in natural settings, why cases rise in some seasons, and which prevention steps make a real difference. The story of Buruli ulcer disease reflects steady progress—from careful observation at the riverside to modern treatments that can limit scarring and protect function when care is started promptly.